Syndax Pharmaceuticals SNDX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's earnings yield?
- Syndax Pharmaceuticals (SNDX) reported earnings yield of -11.8% in Q1 2026.
- How has Syndax Pharmaceuticals's earnings yield changed year-over-year?
- Syndax Pharmaceuticals's earnings yield increased by 62.3% year-over-year, from -31.3% to -11.8%.
- What is the long-term trend for Syndax Pharmaceuticals's earnings yield?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's earnings yield has grown at a 20.7% compound annual growth rate (CAGR), from -6.1% to -15.6%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.